ProfileGDS5678 / 1429077_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.799599
GSM967853U87-EV human glioblastoma xenograft - Control 212.926499
GSM967854U87-EV human glioblastoma xenograft - Control 313.042999
GSM967855U87-EV human glioblastoma xenograft - Control 413.267499
GSM967856U87-EV human glioblastoma xenograft - Control 513.017499
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 112.61799
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 212.523699
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 313.124299
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 413.276899
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 112.97299
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 212.85999
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 313.054399
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.948799
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 513.092499